Rachel K. King

Rachel K. King

Dir., President and Chief Executive Officer at GlycoMimetics, Inc.

Are you Rachel K. King? Claim your profile
 
  • IDENTIFY executive and board member connections in Rachel K. King's network.
  • FOLLOW changes in Rachel K. King's employment.
  • CONNECT with Rachel K. King through your network of contacts.

Rachel K. King's Executive Work History


Current
Dir., President and Chief Executive Officer, GlycoMimetics, Inc.
Board Member, Warp Drive Bio, LLC
Past
To view Rachel K. King's complete executive work history,
Age
58
 
 

Rachel K. King's Biography


Ms. King is a co-founder of our company and has served as our President and Chief Executive Officer and as a member of our Board since our inception in 2003. Previously, Ms. King was an Executive in Residence at NEA from 2001 to 2003. From 1999 to 2001, Ms. King served as a Senior Vice President of Novartis Corporation, a pharmaceutical company. Before joining Novartis, Ms. King spent 10 years with Genetic Therapy, Inc., a biotechnology company, where she served in a number of roles as part of the executive team, which included the company's initial public offering and later acquisition by Novartis. After the acquisition by Novartis, she serv ...

(Read More)

Source: GlycoMimetics, Inc. on 04/13/2018

 

By accessing BoardEdge, you can view bios, network, connections and references of industry leading executives like Rachel K. King. More specifically, you'll be able to:

  • IDENTIFY executive and board member connections in Rachel K. King's network.
  • FOLLOW changes in Rachel K. King's employment.
  • CONNECT with Rachel K. King through your network of contacts.
 

Access over 200,000 executive and board member profiles.

/bio

Example: Rachel K. King

Find a different Rachel King »

Rachel K. King's Connections (144)


Executive Vice President and Chief Commercial Officer, Vertex Pharmaceuticals Incorporated
Chairman of the Board, Acceleron Pharma Inc.
Chief Business Development Officer, Acorda Therapeutics, Inc.
Chair of the Board, President and Chief Executive Officer, Incyte Corporation
Chair of the Board and Chief Executive Officer, Alkermes plc